FerGene
Saint-prex
About FerGene
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals. has been created to potentially commercialize nadofaragne firadenovec in the US and to advance the global clinical development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $570.0M
- Funding stage: Private Equity
- Last round: Private Equity (Nov 2019)
- Website: fergene.com
Industries & Categories
Genetics, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/fergene-18153 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.